Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2009(2): 205-210
DOI: 10.1055/s-0028-1083289
DOI: 10.1055/s-0028-1083289
PAPER
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthesis of 1,4-Benzodiazepine-2,5-diones Using an Ionic Liquid as a Soluble Support
Further Information
Received
31 July 2008
Publication Date:
19 December 2008 (online)
Publication History
Publication Date:
19 December 2008 (online)
![](https://www.thieme-connect.de/media/synthesis/200902/lookinside/thumbnails/10.1055-s-0028-1083289-1.jpg)
Abstract
The first report of the use of an ionic liquid as a soluble support for the synthesis of 1,4-benzodiazepine-2,5-diones is reported in this paper. This synthetic method is simple and efficient and the products are obtained in good yields. All of the products were characterized by IR, ¹H NMR, and ¹³C NMR.
Key words
ionic liquid - synthesis - 1,4-benzodiazepine-2,5-diones - soluble support
- For recent articles on the syntheses and bioactivities of 1,4-benzodiazepine-2,5-diones, see:
-
1a
Kamal A.Reddy KL.Devaiah V. Synlett 2004, 2533 -
1b
Kamal A.Ramana AV.Reddy KS. Tetrahedron Lett. 2004, 45: 818 -
1c
Sabb AL.Vogel RL.Welmaker GS.Sabalski JE.Coupet J.Dunlop J.Rosenzweig-Lipson S.Harrison B. Bioorg. Med. Chem. Lett. 2004, 14: 2603 -
1d
Li XY.Cao H.Zhang CC.Fuchs K. J. Med. Chem. 2003, 46: 5567 -
1e
Parks DJ.LaFrance LV.Calvo RR.Milkiewicz KL.Gupta V.Lattanze J.Ramachandren K.Carver TE.Petrella EC.Cummings MD.Maguire D.Grasberger BL.Lu T. B. Bioorg. Med. Chem. Lett. 2005, 15: 765 - For solid-phase synthesis of 1,4-benzodiazepine-2,5-diones, see:
-
2a
Boojamra CG.Burow KM.Thompson LA.Ellman JA. J. Org. Chem. 1997, 62: 1240 -
2b
Mayer JP.Zhang J.Bjergarde K.Lenz DM.Gaudino JJ. Tetrahedron Lett. 1996, 37: 8081 -
2c
Hulme C.Peng J.Morton G.Salvino JM.Herpin T.Labaudiniere R. Tetrahedron Lett. 1998, 39: 7227 -
2d
Kennedy AL.Fryer AM.Josey JA. Org. Lett. 2002, 4: 1167 - For recent reviews, see:
-
3a
Hermkens PHH.Ottenheijm HCJ.Rees D. Tetrahedron 1996, 52: 4527 -
3b
Booth S.Hermkens PHH.Ottenheijm HCJ.Rees DC. Tetrahedron 1998, 54: 15385 -
3c
Lorsbach BA.Kurth MJ. Chem. Rev. 1999, 99: 1549 -
3d
Guillier F.Orain D.Bradley M. Chem. Rev. 2000, 100: 2091 -
3e
Sammelson R.Kurth MJ. Chem. Rev. 2001, 101: 137 -
3f
Krchòák V.Holladay W. Chem. Rev. 2002, 102: 61 -
3g
Blaney P.Grigg R.Sridharan V. Chem. Rev. 2002, 102: 2607 -
4a
Gravert DJ.Janda KD. Chem. Rev. 1997, 97: 489 -
4b
Wentworth PJ.Janda KD. Chem. Commun. 1999, 1917 -
5a
Toy PH.Janda KM. Acc. Chem. Res. 2000, 33: 546 -
5b
Fishman A.Farrah ME.Zhong JH.Paramanantham S.Carrera C.Lee-Ruff E. J. Org.Chem. 2003, 68: 9843 -
5c
Sauvagnat B.Kulig K.Lamaty F.Lazaro R.Martinez J. J. Comb. Chem. 2000, 2: 134 -
5d
Chen S.Janda KD. J. Am. Chem. Soc. 1997, 119: 8724 -
5e
Lin XF.Zhang J.Wang YG. Tetrahedron Lett. 2003, 44: 4113 -
5f
Wang YG.Lin XF.Cui SL. Synlett 2004, 1175 - 6 For a recent review, see:
Davis JHJ. Chem. Lett. 2004, 33: 1072 -
7a
Fraga-Dubreuil J.Bazureau JP. Tetrahedron Lett. 2001, 42: 6097 -
7b
Miao W.Chan TH. Org. Lett. 2003, 5: 5003 -
7c
Fraga-Dubreuil J.Famelart MH.Bazureau JP. Org. Process Res. Dev. 2002, 6: 374 -
7d
Fraga-Dubreuil J.Bazureau JP. Tetrahedron 2003, 59: 6121 -
8a
Peng HD.Huang YL.Yang JH.Chen ZX.Yang GC. Comb. Chem. High Throughput Screening 2007, 10: 257 -
8b
Zhang HQ.Yang GC.Chen JN.Chen ZX. Synthesis 2004, 3055 -
8c
Rao Z.Peng HD.Yang GC.Chen ZX. Comb. Chem. High Throughput Screening 2006, 9: 1743 -
8d
Chen ZX.Yue GZ.Lu CF.Yang GC. Synlett 2004, 1231 -
8e
Yue GZ.Wan YD.Song SJ.Yang GC.Chen ZX. Bioorg. Med. Chem. Lett. 2005, 15: 453